Brazil has announced that a SARS-CoV-2 vaccine developed by China's Sinovac has a lower effectiveness rate, about 50 percent, than initially thought, CNN reports.
Brazil has announced that a SARS-CoV-2 vaccine developed by China's Sinovac has a lower effectiveness rate, about 50 percent, than initially thought, CNN reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.